Curt joined the healthcare team at Investor Growth Capital in 2005. He focuses on investments in medical device and pharmaceutical companies.
Curt has been involved in healthcare venture capital since 2000 and joined IGC from Tullis-Dickerson, where he worked actively with portfolio companies and sourced new investments. Curt has also spent time in industry with Pfizer's pharmaceuticals business.
Curt holds a B.S. in Economics from Brigham Young University as well as M.D. and M.B.A. degrees from Columbia University. He completed his internal medicine internship at Columbia's St. Luke's-Roosevelt Hospital.
Curt currently serves as a board member for KAI Pharmaceuticals, Myocor and Sirion Therapeutics.